Sporadic Inclusion Body Myositis Correlates with Increased Expression and Cross-linking by Transglutaminases 1 and 2*

Sporadic inclusion body myositis (SIBM) is characterized by vacuolar degeneration of muscle fibers and intrafiber clusters of paired helical filaments with abnormal amyloid deposition. Because of their potential involvement in other degenerative disorders, we have examined the expression of transglutaminases (TGases) in normal and SIBM tissues. We report that at least two different enzymes, the ubiquitous TGase 2 as well as the TGase 1 enzyme, are present in muscle tissues. However, in comparison with normal tissue, the expression of TGases 1 and 2 was increased 2.5- and 4-fold in SIBM, accompanied by about a 20-fold higher total TGase activity. By immunohistochemical staining, in normal muscle, TGase 2 expression was restricted to some endomysial connective tissue elements, whereas TGase 1 and β-amyloid proteins were not detectable. In SIBM muscle, both TGases 1 and 2 as well as amyloid proteins were brightly expressed and co-localized in the vacuolated muscle fibers, but none of these proteins colocalized with inflammatory cell markers. Next, we isolated high molecular weight insoluble proteins from SIBM muscle tissue and showed that they were cross-linked by about 6 residues/1000 residues of the isopeptide bond. Furthermore, by amino acid sequencing of solubilized tryptic peptides, they contain amyloid and skeletal muscle proteins. Together, these findings suggest that elevated expression of TGases 1 and 2 participate in the formation of insoluble amyloid deposits in SIBM tissue and in this way may contribute to progressive and debilitating muscle disease.

[1]  M. Raghunath,et al.  Cross-linking of the dermo-epidermal junction of skin regenerating from keratinocyte autografts. Anchoring fibrils are a target for tissue transglutaminase. , 1996, The Journal of clinical investigation.

[2]  G. Melino,et al.  `Tissue' transglutaminase in cell death: a downstream or a multifunctional upstream effector? , 1998, FEBS letters.

[3]  W. Engel,et al.  Light and electron microscopic localization of beta-amyloid protein in muscle biopsies of patients with inclusion-body myositis. , 1992, The American journal of pathology.

[4]  Soo-Youl Kim,et al.  Differential Expression of Multiple Transglutaminases in Human Brain , 1999, The Journal of Biological Chemistry.

[5]  C. Masters,et al.  Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[6]  B. Festoff,et al.  Cross‐linking of β‐amyloid protein precursor catalysed by tissue transglutaminase , 1994 .

[7]  Kucharz Ej.  [Inclusion body myositis]. , 1998, Polskie Archiwum Medycyny Wewnetrznej.

[8]  S. Younkin,et al.  Expression of β amyloid protein precursor mRNAs: Recognition of a novel alternatively spliced form and quantitation in alzheimer's disease using PCR , 1990, Neuron.

[9]  E. Chiocca,et al.  Isolation and characterization of cDNA clones to mouse macrophage and human endothelial cell tissue transglutaminases. , 1991, The Journal of biological chemistry.

[10]  J. Trojanowski,et al.  Defined neurofilament, tau, and beta-amyloid precursor protein epitopes distinguish Alzheimer from non-Alzheimer senile plaques. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[11]  D. Hohl,et al.  Characterization of human loricrin. Structure and function of a new class of epidermal cell envelope proteins. , 1991, The Journal of biological chemistry.

[12]  R. Graham,et al.  Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function. , 1994, Science.

[13]  L. K. Rasmussen,et al.  Identification of glutamine and lysine residues in Alzheimer amyloid βA4 peptide responsible for transglutaminase‐catalysed homopolymerization and cross‐linking to α2M receptor , 1994, FEBS letters.

[14]  W. Konigsberg,et al.  Removal of sodium dodecyl sulfate from proteins by ion-pair extraction. , 1983, Methods in enzymology.

[15]  T. Bjornsson,et al.  Pharmacologic inhibition of transglutaminase-induced cross-linking of Alzheimer's amyloid beta-peptide. , 1997, Life sciences.

[16]  M. Paulsson,et al.  Tissue Transglutaminase and Factor XIII in Cartilage and Bone Remodeling , 1996, Seminars in thrombosis and hemostasis.

[17]  W. Engel,et al.  Sporadic inclusion-body myositis and hereditary inclusion-body myopathies: diseases of oxidative stress and aging? , 1998, Archives of neurology.

[18]  B. Shroot,et al.  Plasma membrane transglutaminase and cytosolic transglutaminase form distinct envelope‐like structures in transformed human keratinocytes , 1988, FEBS letters.

[19]  H. Green,et al.  The cornified envelope of terminally differentiated human epidermal keratinocytes consists of cross-linked protein , 1977, Cell.

[20]  L. Vignolo,et al.  Differential level of platelet amyloid beta precursor protein isoforms: an early marker for Alzheimer disease. , 1998, Archives of neurology.

[21]  P. Steinert,et al.  Highly Active Soluble Processed Forms of the Transglutaminase 1 Enzyme in Epidermal Keratinocytes (*) , 1995, The Journal of Biological Chemistry.

[22]  J. Kleman,et al.  Transglutaminase-catalyzed cross-linking of fibrils of collagen V/XI in A204 rhabdomyosarcoma cells. , 1995, Biochemistry.

[23]  D. Aeschlimann,et al.  Cell Surface Localization of Tissue Transglutaminase Is Dependent on a Fibronectin-binding Site in Its N-terminal β-Sandwich Domain* , 1999, The Journal of Biological Chemistry.

[24]  F. Campoy,et al.  Activity and Distribution of Tissue Transglutaminase in Association with Nerve‐Muscle Synapses , 1993, Journal of neurochemistry.

[25]  A. Engel,et al.  Monoclonal antibody analysis of mononuclear cells in myopathies. II: Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis , 1984, Annals of neurology.

[26]  N. Seki,et al.  Partial purification and characterization of six transglutaminases from ordinary muscles of various fishes and marine invertebrates. , 1997, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[27]  S. Carpenter.  Inclusion Body Myositis, a Review , 1996, Journal of neuropathology and experimental neurology.

[28]  M. Simon,et al.  Measurement by quantitative PCR of changes in HPRT, PGK-1, PGK-2, APRT, MTase, and Zfy gene transcripts during mouse spermatogenesis. , 1990, Nucleic acids research.

[29]  P. Steinert,et al.  The Proteins Elafin, Filaggrin, Keratin Intermediate Filaments, Loricrin, and Small Proline-rich Proteins 1 and 2 Are Isodipeptide Cross-linked Components of the Human Epidermal Cornified Cell Envelope (*) , 1995, The Journal of Biological Chemistry.

[30]  M. Paulsson,et al.  Cross-linking of laminin-nidogen complexes by tissue transglutaminase. A novel mechanism for basement membrane stabilization. , 1991, The Journal of biological chemistry.

[31]  Soo-Youl Kim,et al.  The Transglutaminase 1 Enzyme Is Variably Acylated by Myristate and Palmitate during Differentiation in Epidermal Keratinocytes* , 1996, The Journal of Biological Chemistry.

[32]  H. Upchurch,et al.  Localization of cellular transglutaminase on the extracellular matrix after wounding: Characteristics of the matrix bound enzyme , 1991, Journal of cellular physiology.

[33]  L. Haynes,et al.  Cellular transglutaminases in neural development , 1993, International Journal of Developmental Neuroscience.

[34]  W. Engel,et al.  beta-Amyloid precursor protein mRNA is increased in inclusion-body myositis muscle. , 1993, Neuroreport.

[35]  M. Motoki,et al.  Transglutaminase-induced cross-linking between subdomain 2 of G-actin and the 636-642 lysine-rich loop of myosin subfragment 1. , 1998, Biophysical journal.

[36]  P. Steinert,et al.  Inactive zymogen and highly active proteolytically processed membrane-bound forms of the transglutaminase 1 enzyme in human epidermal keratinocytes. , 1996, Biochemical and biophysical research communications.

[37]  W. Idler,et al.  Transglutaminase Cross-linking Properties of the Small Proline-rich 1 Family of Cornified Cell Envelope Proteins , 1999, The Journal of Biological Chemistry.

[38]  W. Engel,et al.  Immunolocalization of transcription factor NF-κB in inclusion-body myositis muscle and at normal human neuromuscular junctions , 1998, Neuroscience Letters.

[39]  F. Tagliavini,et al.  A PP Peptide Carboxyl-Terminal to A Is Neurotoxic , 1999 .

[40]  K. Yoneda,et al.  Expression of transglutaminase 1 in human epidermis. , 1995, The Journal of investigative dermatology.

[41]  S. Dimauro,et al.  Inclusion body myositis and myopathies , 1995, Annals of neurology.

[42]  J. Hardy,et al.  Amyloid deposition as the central event in the aetiology of Alzheimer's disease. , 1991, Trends in pharmacological sciences.

[43]  D. Aeschlimann,et al.  Isolation of a cDNA Encoding a Novel Member of the Transglutaminase Gene Family from Human Keratinocytes , 1998, The Journal of Biological Chemistry.

[44]  R. Sasaki,et al.  Cross‐linking of a synthetic partial‐length (1–28) peptide of the Alzheimer β/A4 amyloid protein by transglutaminase , 1993, FEBS letters.

[45]  O. Mcbride,et al.  Structure and organization of the human transglutaminase 1 gene. , 1992, The Journal of biological chemistry.

[46]  V. Thomazy,et al.  Expression of tissue transglutaminase in the developing chicken limb is associated both with apoptosis and endochondral ossification , 1999, Cell Death and Differentiation.

[47]  W. Engel,et al.  β‐Amyloid precursor epitopes in muscle fibers of inclusion body myositis , 1993 .

[48]  S. Dudek,et al.  Transglutaminase facilitates the formation of polymers of the β-amyloid peptide , 1994, Brain Research.

[49]  W. Engel,et al.  Fourteen Newly Recognized Proteins at the Human Neuromuscular Junctions‐and Their Nonjunctional Accumulation in Inclusion‐Body Myositisa a , 1998, Annals of the New York Academy of Sciences.

[50]  M. Paulsson,et al.  Transglutaminase-catalyzed matrix cross-linking in differentiating cartilage: identification of osteonectin as a major glutaminyl substrate , 1995, The Journal of cell biology.

[51]  D. Selkoe.  The molecular pathology of Alzheimer's disease , 1991, Neuron.